Christopher Cioffi

Christopher Cioffi is the Thomas and Constance D'Ambra Professor in Organic Chemistry at Rensselaer Polytechnic Institute's Department of Chemistry and Chemical Biology. His research focuses on medicinal chemistry and organic synthesis, with projects spanning drug discovery for ophthalmic indications, neuropathic pain, COVID-19 therapeutics, and metabolic disorders. The Cioffi Laboratory employs cutting-edge techniques including microwave synthesis, automated chromatography, and LCMS analysis, complemented by structural biology and computational approaches for drug design.

Dr. Cioffi completed his B.S. (1994) and Ph.D. (2000) in Chemistry at Rensselaer Polytechnic Institute. His current research portfolio includes NIH-funded collaborations developing GlyT2 inhibitors for neuropathic pain treatment and bispecific compounds targeting age-related macular degeneration and Stargardt disease. Additional projects investigate novel antiviral agents through the Center for Antiviral Medicines and Pandemic Preparedness.

Recent publications demonstrate Cioffi's multidisciplinary approach, spanning structural biology of viral proteases, allosteric modulation of glycine transporters, and development of novel catalysts for green chemistry applications. His work shows consistent focus on translating mechanistic insights into therapeutic strategies, with frequent collaborations extending to Columbia University, University of Sydney, and Scripps Research Institute.

While no specific awards are mentioned in the provided materials, Cioffi leads an active research group training students in organic synthesis and medicinal chemistry, with significant exposure to pharmacology and pharmacokinetics. The laboratory maintains specialized capabilities in microwave synthesis technology and analytical biochemistry, supported by institutional core facilities at RPI.